ImmuneBiotech Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
2ndary - Private
- Investors
-
5
ImmuneBiotech General Information
Description
Developer of novel therapeutics designed to target the gut microbiota and the immune system. The company focuses on therapeutic bioactive pharmaceutical products including combinations of probiotics, prebiotics, and proteins, in order to confront a range of inflammatory disorders, such as multiple sclerosis, rheumatoid arthritis, and type 1 diabetes, enabling healthcare professionals to prevent and treat autoimmune and other chronic inflammatory condition.
Contact Information
Website
www.immunebiotech.comCorporate Office
- Scheelevägen 2
- Medicon Village
- 223 81 Lund
- Sweden
Corporate Office
- Scheelevägen 2
- Medicon Village
- 223 81 Lund
- Sweden
ImmuneBiotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Secondary Transaction - Private | 01-Apr-2026 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 20-Jan-2021 | Completed | Generating Revenue | |||
| 9. Angel (individual) | 23-Sep-2020 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 01-Jan-2020 | Completed | Generating Revenue | |||
| 7. Grant | 30-Sep-2019 | Completed | Generating Revenue | |||
| 6. Angel (individual) | 24-Jan-2019 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | Completed | Startup | ||||
| 3. Angel (individual) | 16-Feb-2018 | $313K | $313K | Completed | Startup | |
| 2. Accelerator/Incubator | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ImmuneBiotech Signals
ImmuneBiotech Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| I Love Lund | Family Office | Minority | ||
| European Union | Government | Minority | ||
| Angel (individual) | Minority | |||
| EASME - EU Executive Agency for SMEs | Corporation | |||
| Lund University | University |
ImmuneBiotech FAQs
-
When was ImmuneBiotech founded?
ImmuneBiotech was founded in 2013.
-
Where is ImmuneBiotech headquartered?
ImmuneBiotech is headquartered in Lund, Sweden.
-
What is the size of ImmuneBiotech?
ImmuneBiotech has 5 total employees.
-
What industry is ImmuneBiotech in?
ImmuneBiotech’s primary industry is Drug Discovery.
-
Is ImmuneBiotech a private or public company?
ImmuneBiotech is a Private company.
-
What is ImmuneBiotech’s current revenue?
The current revenue for ImmuneBiotech is .
-
How much funding has ImmuneBiotech raised over time?
ImmuneBiotech has raised $2.71M.
-
Who are ImmuneBiotech’s investors?
I Love Lund, European Union, , EASME - EU Executive Agency for SMEs, and Lund University have invested in ImmuneBiotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process